Tune In! Our CEO Andrew Cavey recently joined Dr Oliver Sartor on the podcast “Leaders in Radiopharmaceuticals: Disruptive Innovations and Personal Perspectives”, hosted by UroToday. Together, they dive into the evolving role of radiopharmaceuticals in advancing cancer treatment and explore the potential future pathways for our industry.
This thought-provoking conversation is now available to stream for free on UroToday + GU OncToday’s website – an insightful listen for anyone interested in the latest innovations in radiopharmaceuticals.
For 20 years, ITM has evolved from a startup in Garching, near Munich, to a global leader in radiopharmaceuticals, pioneering innovative targeted treatments to improve cancer treatments. Our journey reflects a commitment to precision medicine and better patient outcomes worldwide. We’re excited to share our story of ITM’s 20 year journey with you in a video.
Come celebrate with us by visiting our 20th Anniversary Microsite.
An international collaboration between ITM, Bruce Power and Isogen (a Kinectrics and Framatome company), announced a milestone marking the first instance lutetium-177, a short-lived medical isotope, has been produced in a commercial nuclear power reactor.
Watch our virtual tour for an impression of ITM, our sites and our daily work.
ITM's highly scientific Satellite Symposium “Challenges and Innovative Approaches in the Management of Osteoblastic Metastatic Disease” at virtual EANM Congress 2020 was a great success.
See our image video and learn about Targeted Radionuclide Diagniostics and Therapies in Precision Oncology.
ITM's highly scientific Radiotheranostics Satellite Symposium “Novel Approaches to Optimizing Targeted Radionuclide Therapy in Neuroendocrine Neoplasms” at ENETS 2020 was a great success. Here a short compilation.
Prof M Caplin, Prof P Ruszniewski, Dr G Nicolas and Dr S Glasberg discussed about “Towards Optimizing the Application of Radiotheranostics in the Management of NET Patients” at ENETS 2019.
PRRT as treatment option for cancers like neuroendocrine tumors. See a practicing physician and two patients talking about their experience.
Alex enjoys the freedom that he gets working at ITM. He really appreciates that he can contribute to the development of the department and even to the development of the company. Watch Alex explain his unique view on ITM and "Passion for Precision".
#ITMpassion (4/5)
Rabaa has made many friends at ITM what has been helpful to integrate fast. Rabaa loves her colleagues and she says, “ITM is my little family”. See Rabaa talking about her work with medical radionuclides and what she is thinking about “Passion for Precision”.
#ITMpassion (3/5)
Andrea is inspired by people who actively try to get things moving. She says, she has rarely met so many highly motivated and dedicated people in the field of Biotechnology and Precision Oncology as those at ITM. See Andrea talking about “Passion for Precision” at ITM.
#ITMpassion (2/5)
